Vigil Neuroscience Funding & Investors
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
vigilneuro.comTotal Amount Raised: $140,000,000
Vigil Neuroscience Funding Rounds
Series B
$90,000,000
Series B Investors
Logos CapitalVida VenturesAtlas VentureSurveyor CapitalHatteras Venture PartnersLightstone VenturesInvus GroupCormorant Asset ManagementOrbiMed AdvisorsRock Springs CapitalDeep Track CapitalNorthpond VenturesPivotal bioVenture PartnersSeries A
$50,000,000
Series A Investors
Hatteras Venture PartnersAtlas VentureNorthpond VenturesAlexandria Venture Investments
Funding info provided by Diffbot.